Skip to main content
Funded Studies

Douglas W. Bonhaus, PhD

Chief Executive Officer at Neuropore Therapies, Inc.

Location: San Diego, CA United States

Douglas Bonhaus, PhD, is a drug-discovery scientist with more than twenty years of experience in the pharmaceutical industry. Initially trained in pharmacology and toxicology at the University of Arizona, Bonhaus has held leadership positions at Syntex, Roche and ACADIA Pharmaceuticals. He is the cofounder of Denysias Bioscience, a company focused on developing novel therapies for impulse control disorders in patients with Parkinson’s disease, now entering clinical stages. Bonhaus now serves as the President and Chief Executive Officer of Neuropore Therapies.

Associated Grants

  • Preclinical and Early Clinical Development of NPT1220-478 for the Treatment of Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.